Proteomics & Protein Research

The investigators used the technique to identify two novel secretome targets and then confirmed them to be elevated in the blood of women with cancer.

The study, funded last month by the NIH, will use SRM-MS to identify proteins from a subset of promising pathways that are associated with DKD patients' progression to end-stage disease.

The registry is expected to yield a "validated, semi-quantitative risk assessment algorithm that will assist physicians in managing patients at risk for ovarian cancer."

The deal gives EMD Millipore control of Singulex's single-molecule counting technology for research applications.

The company plans to launch the test, which uses serial CA-125 measurements, in theUKthis summer and in theUSlater this year.